Wegovy is FDA-approved for weight management, while Ozempic is FDA-approved for type 2 diabetes but may be prescribed off-label for weight loss
Pre-Treatment Readiness: Who Benefits and Important Safety Considerations Semaglutide is appropriate for adults with weight-related conditions or type 2 diabetes under medical supervision
However, the significant weight loss it promotes can lead to a temporary condition called telogen effluvium, which is responsible for most hair thinning users report
Meta-analyses of nitric-oxide precursors show modest gains in endurance and power- output metrics, suggesting parenteral arginine-citrulline may provide similar, though still investigational, benefits when overseen by trained clinicians
And it's a series of studies with different designs and populations to look, in randomized controlled trials that's the highest level evidence at what this drug would do for individuals with obesity, individuals with obesity who also had diabetes, what about if we add intensive lifestyle therapy to it, what would happen if we stopped the medication, what about individuals living with arthritis or with heart failure or heart disease
Carnitine and left ventricular function in haemodialysis patients